Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-243-4 | CAS number: 931-87-3
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991-02-25 to 1991-04-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- (Z)-cyclooctene
- EC Number:
- 213-243-4
- EC Name:
- (Z)-cyclooctene
- Cas Number:
- 931-87-3
- Molecular formula:
- C8H14
- IUPAC Name:
- (Z)-cyclooctene
- Details on test material:
- cyclooctene of Hüls AG, Sample from B 803, ID No. 3630/81 288, produced December 1990.
Purity 96.2 % (GC-FID area).
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS:
- Strain: Dunkin-Hartley, Pirbright White, BOR:DHPW (SPF)
- Sex: female
- Source: Fa. Winkelmann, Borchen (Germany)
- Age: healthy young adults
- Weight at study initiation: 464 g (mean test); 460 g, 457 g (means control groups 1 and 2)
- Controls: 10 each for 1st and 2nd challenge; treatment: vehicle
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: corn oil (MEH 56)
- Concentration / amount:
- 1st challenge: 100 % (0.20 ml) with patch on left side (control group: 1)
2nd challenge: 10 % (0.12 ml) with patch on right side (control group: 2)
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: corn oil (MEH 56)
- Concentration / amount:
- 1st challenge: 100 % (0.20 ml) with patch on left side (control group: 1)
2nd challenge: 10 % (0.12 ml) with patch on right side (control group: 2)
- No. of animals per dose:
- test: 20
control: 10 - Details on study design:
- 1st application: Induction 2.5 % intracutaneous
2nd application: Induction undiluted occlusive epicutaneous
3rd application: Challenge undiluted occlusive epicutaneous
ADMINISTRATION/EXPOSURE
- Preparation of test substance for induction: clear solution in vehicle
- Induction schedule:
day 0 injection,
day 6 induction of slight to moderate skin irritation (10 % sodium dodecyl sulfate in petrolatum)
days 7-9 patch treatment (0.25 ml, 48 hours), readings 1 and 24 hours after patch removal
- Injection details: 0.1 ml each at 6 positions on shoulders:
2 x Freund's Complete Adjuvant / deionized water (50:50)
2 x test substance 2.5 % in corn oil
2 x test substance 2.5 % in Freund's Complete Adjuvant / corn oil (50:50) simultaneous and symmetrical application of each solution
controls: corn oil instead of test substance
- Challenge schedule: 1st challenge on day 21, 2nd challenge on day 28 occlusive patch treatment for 24 hours,
readings 24, 48, 72 hours after administration
- Concentrations used for challenge:
1st challenge: 100 % (0.20 ml) with patch on left side (control group: 1)
2nd challenge: 10 % (0.12 ml) with patch on right side (control group: 2)
- Positive control: 1-chloro-2,4-dinitrobenzene
EXAMINATIONS
- Grading system: as usual for skin irritation, 0-8 scores possible
- Pilot study: dose finding (intracutaneous toxicity and skin irritation)
intracutaneous doses: 0.1 ml x 0; 0.25; 0.50; 1.0; 2.5; 5.0; 10.0 % w/w,
2 animals each dermal doses: 0.1 ml x 2.5; 25; 50; 100 % w/w
4 animals each with 4 different concentrations at different sites
24 hour occlusive patch test, readings 24 / 48 / 72 hours after administration - Positive control substance(s):
- yes
- Remarks:
- 1-chloro-2,4-dinitrobenzene
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- see below
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100 %. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: see below.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Clinical observations:
- see below
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 100 %. No with. + reactions: 8.0. Total no. in groups: 10.0. Clinical observations: see below.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- see below
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 100 %. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: see below.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Clinical observations:
- see below
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 100 %. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: see below.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 10 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 10 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 72.0. Group: test group. Dose level: 10 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 72.0. Group: negative control. Dose level: 10 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.
Any other information on results incl. tables
RESULTS OF PILOT STUDY:
2.5 % was chosen for intracutaneous induction
100 % test substance caused no dermal irritation
RESULTS OF TEST
- Sensitization reaction:
1st challenge: inconclusive results due to irritation in both test and control groups.
2nd challenge: 0/20 animals positive at 48 hours and at 72 hours after application = no sensitization, no animals positive in
control group
- Clinical signs: No signs of systemic toxicity were observed.
1st induction, FCA + water application sites: severe erythema, severe edema, and deep wounds within 24 hours.
1st induction, test substance + vehicle application sites: distinct erythema, very slight edema within 1 hour; very slight erythema
within 24 hours, edema were absent in 9/20 animals.
1st induction, vehicle application sites: distinct erythema, very slight edema within 1 hour; very slight erythema left in only 5/20
animals and no more edema within 24 hours.
1st induction, FCA + test substance application sites: distinct to severe erythema, severe edema and (in 8/20 animals) deep
wounds within 24 hours.
1st induction, FCA + vehicle application sites: severe erythema and edema and necrosis within 24 hours.
2nd induction, FCA + water application sites: severe erythema and edema wih deep wounds within 1 hour after patch removal;
eschar formation within 24 hours
2nd induction, test substance + vehicle application sites: eschar formation 1 and 24 hours after patch removal
2nd induction, vehicle application sites: eschar formation 1 and 24 hours after patch removal
2nd induction, FCA + test substance application sites: eschar formation 1 hour after patch removal, 1 animal with deep wounds
and severe edema; 24 hours after patch removal eschar in 14/20 animals, severe edema and crusts on heavy erythema with
deep wounds in 6/20 animals.
2nd induction, FCA + vehicle application sites: 1 hour after patch removal eschar in 14/20 animals, severe erythema and
edema with deep wounds in 6/20 animals. 24 hours after patch removal eschar formation at injection sites of 9/20 animals,
severe edema and incrustation on severe erythema / deep wounds in other 11 animals.
1st challenge, test group: 24 hours after patch removal very slight to distinct erythema and edema in all animals; 24 hours later
the edema had disappeared in 3/20 animals.
1st challenge, control group 1: 24 hours after patch removal very slight to distinct erythema and (in 8/10 animals) edema; 24 hours
later the edema were absent in 3/10 animals.
2nd challenge: no signs of irritation in test group and control group 2.
- Other: Body weight development was similar in test and control groups.
Applicant's summary and conclusion
- Conclusions:
- No skin sensitization was induced by the test material. In this study, cyclooctene is not a dermal sensitizer.
- Executive summary:
In a dermal sensitization study with cyclooctene in corn oil, was tested in a group of young Dunkin-Hartley guinea pigs using the method of Magnusson and Kligman. 1-Chloro-2,4-dinitrobenzene served as positive control material. No signs of systemic toxicity were noted.
No skin sensitization was induced by the test material. In this study, cyclooctene is not a dermal sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
